Theorist position for analysis 687fb884-6d31-47c3-a83f-074bad980db6: Cell-Autonomous vs Non-Cell-Autonomous Mechanisms of Mutant FUS Neuromuscular Denervation
Source basis: The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis (Nature Communications, 2025, DOI 10.1038/s41467-025-62351-3). The stored gap context says: NMJ denervation study identified myeloid cell involvement; cell-autonomous vs. non-cell-autonomous contributions of FUS mutations to NMJ pathology were not separated in the experimental design.
Primary hypothesis: mutant FUS effects split between motor-neuron intrinsic stress and glial/NMJ inflammatory signaling is not merely an associated signature; it is a testable mechanism that can explain the open question: What are the relative contributions of cell-autonomous motor neuron mechanisms versus non-cell-autonomous astrocyte and microglia mechanisms in mutant FUS-driven neuromuscular denervation in ALS — and do patient-derived chimeric co-culture systems with isogenic controls reveal independent glial contributions to NMJ dysfunction?
Three candidate claims should be carried forward. First, the strongest causal signal should appear in the cell type or tissue compartment named by the question, not only in bulk disease contrasts. Second, perturbing the axis should shift a proximal molecular phenotype before it shifts a late pathology phenotype, which would help separate cause from consequence. Third, the relevant readout should be stratified by FUS, FUS-, ALS, NMJ, because collapsing across those terms would erase the mechanism the analysis is trying to test.
The priority experiment is isogenic motor-neuron, astrocyte, and microglia chimeric co-cultures with NMJ formation and denervation readouts. A positive result would require concordance across human observational data, disease-relevant cellular models, and at least one perturbation that moves the predicted proximal readout in the expected direction.